Anticoagulation for atrial fibrillation patients with CHADS2 score of 1

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 5, 2010, Pages 508-510

  Lane, Deirdre A ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DABIGATRAN; TICLOPIDINE; WARFARIN;

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIABETES MELLITUS; EMBOLISM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STROKE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE; THROMBOEMBOLISM;

EID: 77949579636     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2009.01687.x     Document Type: Article

References (16)

1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ : Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001 285 : 2864 2870.
2. National Collaborating Centre for Chronic Conditions : Atrial fibrillation: National clinical guideline for management in primary and secondary care.
3. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society : ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114 : e257 e354.
4. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ, American College of Chest Physicians : Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 : 546S 592S.
5. Lane DA, Lip GYH : Barriers to anticoagulation in patients with atrial fibrillation: Changing physician-related factors. Stroke 2008 39 : 7 9.
6. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, RE-LY Steering Committee and Investigators : Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009 361 : 1139 1151.
7. Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN : The effect and safety of the anti-thrombotic therapies in patients with atrial fibrillation and CHADS2 score 1. J Cardiovasc Electrophysiol, DOI
8. Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, De Caterina R, Flaker G, Yusuf S, Connolly SJ : Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: The Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE-W). Stroke 2008 39 : 1482 1486.
9. Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S, ACTIVE W Investigators : Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 2008 118 : 2029 2037.
10. Morgan CL, McEwan P, Tukiendorf A, Robinson PA, Clemens A, Plumb JM : Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control. Thromb Res 2009 124 : 37 41.
11. ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S : Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial. Lancet 2006 367 : 1903 1912.
12. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS : The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009 151 : 297 305.
13. Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM : Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest 2009 DOI
14. Lakshminarayan K, Anderson DC, Jacobs DR Jr., Barber CA, Luepker RV : Stroke rates: 1980-2000: The Minnesota Stroke Survey. Am J Epidemiol 2009 169 : 1070 1078.
15. Devereaux P, Anderson D, Gardner M, Putnam W, Flowerdew G, Brownell BF, Nagpal S, Cox JL : Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: Observational study. BMJ 2001 323 : 1218 1222.
16. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E, BAFTA investigators; Midlands Research Practices Network (MidReC) : Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged study, BAFTA): A randomized controlled trial. Lancet 2007 370 : 493 503.